Aktienanalyse zu FMC Corp (FMC)FMCFMC Corp

FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products. It operates in the Basic Materials sector (CHEMICALS & ALLIED PRODUCTS industry).

FMC Corp is not a good buy right now due to severe financial challenges and a significant drop in revenue guidance. The current price is $5.05, and the company has cut its Q3 revenue outlook from $840-$900 million to a range of $65-$125 million, indicating a drastic decline in demand. Additionally, the RSI is at an extremely low 7.004, suggesting oversold conditions but also reflecting the ongoing bearish sentiment. The main risk is the projected adjusted EBITDA loss of $510 million to $565 million, which highlights the company's financial instability and could lead to further declines in stock value.

21 analysts cover FMC: 13 rate it Buy, 8 Hold and 0 Sell. The average price target is 19.08.